FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/02/011875 [Registered on: 13/02/2018] Trial Registered Prospectively
Last Modified On: 28/01/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Diet Regimen]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to study the effect of triphala lauha in the patients of Amlapitta( gastric disorders like heartburn,indigestion, nausea etc) 
Scientific Title of Study   To study the efficacy of triphala lauha in disintegration of aetiopathogenesis of Amlapitta  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prof Dr Vidula Gujjarwar 
Designation  Proffesor 
Affiliation  Ch. Brahm Prakash Ayurved Charak Sansthan Khera Dabar, Najafgarh  
Address  Department of Rog Nidan Evum Vikriti Vigyan Ch. Brahm Prakash Ayurved Charak Sansthan Khera Dabar Njafgarh New delhi

New Delhi
DELHI
110073
India 
Phone  9990174348  
Fax    
Email  shreemahalaxmi1969@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Vidula Gujjarwar 
Designation  Proffesor 
Affiliation  Ch. Brahm Prakash Ayurved Charak Sansthan Khera Dabar, Najafgarh  
Address  Department of Rog Nidan Evum Vikriti Vigyan Ch. Brahm Prakash Ayurved Charak Sansthan Khera Dabar Njafgarh New delhi

New Delhi
DELHI
110073
India 
Phone  9990174348  
Fax    
Email  shreemahalaxmi1969@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr Vidula Gujjarwar 
Designation  Proffesor 
Affiliation  Ch. Brahm Prakash Ayurved Charak Sansthan Khera Dabar, Najafgarh  
Address  Department of Rog Nidan Evum Vikriti Vigyan Ch. Brahm Prakash Ayurved Charak Sansthan Khera Dabar Njafgarh New delhi

New Delhi
DELHI
110073
India 
Phone  9990174348  
Fax    
Email  shreemahalaxmi1969@gmail.com  
 
Source of Monetary or Material Support  
Ch.Brahm Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh New Delhi 110073 
 
Primary Sponsor  
Name  Ch Brahm Prakash Ayurved Charak Sansthan 
Address  Khera Dabar Najafgarh New Delhi 
Type of Sponsor  Other [State Government Ayurvedic College] 
 
Details of Secondary Sponsor  
Name  Address 
Department of trog Nidan Evum Vikriti Vigyan  Ch Brahm Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh New Delhi 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Prof Dr Vidula Gujjarwar  Ch.Brahm Prakash Ayurved Charak Sansthan Khera Dabar, Najafgarh   OPD no. 20 and 22 of Rog Nidan and Atayayika vibhag
New Delhi
DELHI 
9990174348

shreemahalaxmi1969@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC Ch Brahm Prakash Ayurved Charak Sansthan NCT Delhi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Patients of Amlapitta disease,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  No Treatment  Fixed Diet Regimen 
Intervention  Triphala Lauha  250 mg BD for 45 days Fixed diet Regimen 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1. Patients of either sex
2. Patients with age group between 25-55 years
3. Patients with symptoms of Amlapitta like Amlaudgara(sour belching)Daha(burning sensation )Chhardi(vomiting) Shoola(pain)
4.Patients having symptoms of Amlapitta for more than 7 days
5.Patients taking modern medicines
 
 
ExclusionCriteria 
Details  1.Patients of age below 25 years and more than 55 years
2.Patients of severe vomiting and dehydration
3.Pregnant women and lactating mother
4.Patients with gastric malignancy
5.Patients having addiction of alcohol
6.Patients who recently undergone gastrointestinal surgery 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in symptoms of amlapitta  Every 15 days  
 
Secondary Outcome  
Outcome  TimePoints 
Relief in symptoms of Amlapitta  every 15 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/03/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   In today’s life there is continuously change in life style and dietary habits of the people. Most of the people are crazy for junk foods and some, due to their busy schedule do not even bother to take proper diet. In both of the conditions,the body elements vata, pitta and kapha gets vitiated and leads to various disorders, Amlapitta is one among the various gastrointestinal diseases which occurs due to vitiation of pitta dosha. Whenever due to improper digestion amlta of Pitta is increased it leads to Amlapitta disease.Now a days it becomes a worldwide disease and it is increases day by day. There are so many drugs available who works on it but still some more researches are required to get more effective, inexpensive and safe drugs. Triphala lauha is mentioned in chakradutta in Parinam shooladhyaya for the cure of amlapitta disease. Contents of this drug are aamlaki, vibhitaki and haritaki in same proportion. This trial is oriented towards knowing of aetiopathogenesis oand management of Amlapitta.

Assessment Criteria

Subjective improvement will be assessed by adopting suitable scoring methods

Study Type                Randomized Comparative Clinical Trial

Intervention time      45 days

Sample Size              60 ( 30 in each group)

Group A                     Triphala Lauha 250 mg BD and fixed diet regimen

Group B                      Fixed diet regimen


 
Close